Cited by 19Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryOcular Surface and Contact Lens

Combination of self-assembling system and N,O-Carboxymethyl chitosan improves ocular residence of anti-glaucoma drug

Kailasam, Velmurugan, Kumara, Bommanahalli Nagaraju, Prasad, K. Sudhakara, Nirmal, Jayabalan·2024·European Journal of Pharmaceutics and Biopharmaceutics

Abstract

Glaucoma is known to be one of the principal causes of vision loss due to elevated intraocular pressure. Currently, latanoprost eye drops is used as first-line treatment for glaucoma; however, it possesses low bioavailability due to rapid precorneal clearance. A novel delivery system with a mucoadhesive property could overcome this problem. Therefore, we attempt to develop a combination of self-assembling latanoprost nanomicelles (Latcel) and a mucoadhesive polymer (N,O-carboxymethyl chitosan: N,O-CMC) to improve the corneal residence time. Latcel was developed using Poloxamer-407 by thin film hydration method, followed by the addition of N,O-CMC using simple solvation to obtain Latcel-CMC and characterized using various physicochemical characterization techniques. The particle size of Latcel-CMC was 94.07 ± 2.48 nm and a zeta potential of -16.03 ± 0.66 mV, with a sustained release for 24h whereas marketed latanoprost drops released 90 % of the drug within 1h. In vitro cytotoxicity studies, HET-CAM, and in vivo Draize test showed the biocompatibility of Latcel-CMC. Cellular uptake studies performed using fluorescein isothiocyanate (FITC) loaded nanomicelles in human corneal epithelial cells indicates the increased cellular uptake as compare to plain FITC solution. In vivo ocular residence time was evaluated in Wistar rats using Indocyanine green (ICG) loaded nanomicelles by an in vivo imaging system (IVIS), indicating Latcel-CMC (8h) has better residence time than plain ICG solution (2h). The Latcel-CMC showed improved corneal residence time and sustained release of latanoprost due to increased mucoadhesion. Thus, the developed N,O-Carboxymethyl chitosan based nanomicelles eye drop could be a better strategy than conventional eye drops for topical delivery of latanoprost to treat glaucoma.

Integrity signals

Registry

Crossref · 10.1016/j.ejpb.2024.114208

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Latcel-CMC in New Zealand white rabbits confirmed the drug has 24-h continuous release ability and good biocompatibility, and eye retention time is extended to 8 h, much higher than 2 h of the ordinary solution.

    “The in vivo experiment in New Zealand white rabbits confirmed that the drug has a 24-h continuous release ability and good biocompatibility, and the eye retention time is extended to 8 h, which is much higher than 2 h of the ordinary solution”

Cites

Flagged first, then by citations

1 of the 61 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kailasam, V., Kumara, B. N., Prasad, K. S., & Nirmal, J.
Affiliations
  • Birla Institute of Technology and Science - Hyderabad Campus (IN)
  • Yenepoya University (IN)
Corresponding author
  • Prasad, K. Sudhakara
  • Nirmal, Jayabalan
Venue
European Journal of Pharmaceutics and Biopharmaceutics
Publisher
Elsevier BV
Published
2024-04
Volume
197
Pages
114208
ISSN
0939-6411 (ISSN-L)
OpenAlex
W4391617409
Cited by
19
References
61
Citations by year
2026: 2 · 2025: 14 · 2024: 3
FWCI
3.27
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Pharmaceutics and Biopharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
Department of Science and Technology
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ocular Surface and Contact Lens
Keywords
latanoprost, glaucoma, ocular drug delivery, Pluronic F127, N,O-carboxymethyl chitosan, mucoadhesion, ocular residence time, sustained drug release, eye drops, corneal epithelial cells, biocompatibility, topical ocular drug delivery
MeSH terms
Latanoprost, Antiglaucoma Agents, Animals, Cornea, Delayed-Action Preparations, Drug Carriers, Glaucoma, Humans, Ophthalmic Solutions, Drug Delivery Systems, Fluorescein-5-isothiocyanate, Rats, Wistar, Chitosan, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review